Potassium Citrate Tablet, Extended Release
Product Images NDC 72865-191

5 FDA label images from Xlcare Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 72865-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

10meq

10meq
Label for Potassium Citrate Extended-Release Tablets, USP 10 mEq (1080 mg) per tablet, oral dosage form, manufactured for XLCare Pharmaceuticals, Inc. The label states the product is prescription only, contains 100 tablets, and includes storage, packaging, and manufacturing information from Ascent Pharmaceuticals, Inc.*
FDA Label Image

15meq

15meq
Potassium Citrate Extended-Release Tablets, USP 15 mEq (1620 mg) per tablet, oral dosage form. The label displays the product name, strength, and quantity of 100 tablets. It is manufactured by Ascent Pharmaceuticals, Inc. for XLCare Pharmaceuticals, Inc. The label includes storage and handling instructions and the National Drug Code (NDC 72865-193-01).*
FDA Label Image

5meq

5meq
Potassium Citrate Extended-Release Tablets USP 5 mEq (540 mg) per tablet oral dosage form label by XLCare Pharmaceuticals, Inc. The label indicates 100 tablets per container, with instructions for storage, tablet characteristics, and manufacturer information for Ascent Pharmaceuticals, Inc. and XLCare Pharmaceuticals, Inc. The NDC code is 72865-191-01.*
FDA Label Image

Table 1.

Table 1.
A table titled 'Effect of Potassium Citrate In Patients With Calcium Oxalate Nephrolithiasis' showing the number of stones formed per year among four patient groups at baseline, on treatment, and remission rates. It also includes total patient data (n=89) with values for baseline, treatment, remission percentage, and any decrease in stone formation during treatment.*
FDA Label Image

Structure.

Structure.
Chemical structure of potassium citrate monohydrate, showing a central carbon atom bonded to three CH2COOK groups and one hydroxyl group, with an associated water molecule (H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.